NCT06628960 Effect of Su Jok Therapy on Breastfeeding
| NCT ID | NCT06628960 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aysegul Kilicli |
| Condition | Breastfeeding |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-10-09 |
| Primary Completion | 2025-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-10-09 with a primary completion date of 2025-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There are many alternative methods to increase breast milk. In the literature, studies on Su Jok therapy applications are limited and no studies on increasing breast milk have been found. In Korean language, 'Su' means hand and 'Jok' means foot. Su Jok therapy is defined as a modern acupressure/acupuncture interpretation that utilises the body's independent communication systems on the hands and feet by applying various techniques such as massage, moxa (heating), needles, magnets and seeds to the reflection points on the hands and feet. Su Jok is an integrated therapy that incorporates many tried and trusted methods of oriental medicine
Eligibility Criteria
Inclusion Criteria: * primiparous women giving birth by caesarean section, * women aged 19-35, * breastfeeding women Exclusion Criteria: * those who refused to participate in the research
Contact & Investigator
AYŞEGÜL KILIÇLI, Assisstan. Prof. PhD.
PRINCIPAL INVESTIGATOR
Muş Alparslan University
Frequently Asked Questions
Who can join the NCT06628960 clinical trial?
This trial is open to female participants only, aged 19 Years or older, up to 35 Years, studying Breastfeeding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06628960 currently recruiting?
Yes, NCT06628960 is actively recruiting participants. Contact the research team at aysegul_ay_9@hotmail.com for enrollment information.
Where is the NCT06628960 trial being conducted?
This trial is being conducted at Sanliurfa, Turkey (Türkiye).
Who is sponsoring the NCT06628960 clinical trial?
NCT06628960 is sponsored by Aysegul Kilicli. The principal investigator is AYŞEGÜL KILIÇLI, Assisstan. Prof. PhD. at Muş Alparslan University. The trial plans to enroll 60 participants.